This content is restricted to ESCMID Members and to non-members that have registered.
References
Discussion Forum (0)
1. 1. Singhal T, Rodrigues C, Soman R, Wattal C, Swaminathan S, Nambi S, et al. Treatment of MRSA infections in India: Clinical insights from a Delphi analysis. Indian Journal of Medical Microbiology. 2022 Jan 1;40(1):35–45.
2. 1. Corona A, De Santis V, Agarossi A, Prete A, Cattaneo D, Tomasini G, et al. Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review. Antibiotics (Basel). 2023 Jul 31;12(8):1262.
3. 1. Cillóniz C, Garcia-Vidal C, Ceccato A, Torres A. Antimicrobial Resistance Among Streptococcus pneumoniae. Antimicrobial Resistance in the 21st Century. 2018 Mar 7;13–38.
4. 1. IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections [Internet]. [cited 2024 Mar 10]. Available from: https://www.idsociety.org/practice-guideline/amr-guidance/
Targeted Therapy in MDRO setting
Dr. Sneha Radha
Affiliations:
Department of Infectious diseases, Aster Medcity
Department of Infectious diseases, Aster Medcity
References
Discussion Forum (0)
1. 1. Singhal T, Rodrigues C, Soman R, Wattal C, Swaminathan S, Nambi S, et al. Treatment of MRSA infections in India: Clinical insights from a Delphi analysis. Indian Journal of Medical Microbiology. 2022 Jan 1;40(1):35–45.
2. 1. Corona A, De Santis V, Agarossi A, Prete A, Cattaneo D, Tomasini G, et al. Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review. Antibiotics (Basel). 2023 Jul 31;12(8):1262.
3. 1. Cillóniz C, Garcia-Vidal C, Ceccato A, Torres A. Antimicrobial Resistance Among Streptococcus pneumoniae. Antimicrobial Resistance in the 21st Century. 2018 Mar 7;13–38.
4. 1. IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections [Internet]. [cited 2024 Mar 10]. Available from: https://www.idsociety.org/practice-guideline/amr-guidance/
{{ help_message }}
{{filter}}